These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 93926

  • 1. Identity and properties of multiple neuroleptic-binding sites in rat limbic brain areas [proceedings].
    Leysen JE.
    Arch Int Physiol Biochim; 1979 Oct; 87(4):822-4. PubMed ID: 93926
    [No Abstract] [Full Text] [Related]

  • 2. Anomalous properties of [3H]spiperone binding sites in various areas of the rat limbic system.
    Howlett DR, Morris H, Nahorski SR.
    Mol Pharmacol; 1979 May; 15(3):506-14. PubMed ID: 492143
    [No Abstract] [Full Text] [Related]

  • 3. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
    Akiyama K, Sato M, Otsuki S.
    Biol Psychiatry; 1982 Feb; 17(2):223-31. PubMed ID: 7200378
    [Abstract] [Full Text] [Related]

  • 4. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
    Akiyama K, Sato M, Kashihara K, Otsuki S.
    Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
    [Abstract] [Full Text] [Related]

  • 5. [3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors.
    Palacios JM, Niehoff DL, Kuhar MJ.
    Brain Res; 1981 Jun 01; 213(2):277-89. PubMed ID: 7248759
    [Abstract] [Full Text] [Related]

  • 6. The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitro.
    Howard JL, Large BT, Wedley S, Pullar IA.
    Life Sci; 1978 Aug 14; 23(6):599-603. PubMed ID: 29198
    [No Abstract] [Full Text] [Related]

  • 7. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes.
    Howlett DR, Nahorski SR.
    FEBS Lett; 1978 Mar 01; 87(1):152-6. PubMed ID: 631328
    [No Abstract] [Full Text] [Related]

  • 8. The [3H]5-HT and [3H]spiroperidol binding sites in the rat frontal cortex and thermally inactivated at different rates.
    Poller D, Carroll JA, Middlemiss DN.
    Eur J Pharmacol; 1981 Jun 10; 72(1):121-3. PubMed ID: 7262190
    [No Abstract] [Full Text] [Related]

  • 9. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S, Robson PA.
    Neuropharmacology; 1981 Dec 10; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract] [Full Text] [Related]

  • 10. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site.
    Beart PM, Krstich M, McDonald D, Gundlach AL.
    Neurosci Lett; 1982 Apr 16; 29(2):147-51. PubMed ID: 6123968
    [Abstract] [Full Text] [Related]

  • 11. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging.
    Thal LJ, Horowitz SG, Dvorkin B, Makman MH.
    Brain Res; 1980 Jun 16; 192(1):185-94. PubMed ID: 7378779
    [Abstract] [Full Text] [Related]

  • 12. Kinetic investigation of [3H] spiperone-binding sites in rat frontal cortex [proceedings].
    Leysen JE, Gommeren W, Laduron P.
    Arch Int Physiol Biochim; 1978 Oct 16; 86(4):874-6. PubMed ID: 84588
    [No Abstract] [Full Text] [Related]

  • 13. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ, Snyder SH.
    Mol Pharmacol; 1979 Nov 16; 16(3):687-99. PubMed ID: 530254
    [No Abstract] [Full Text] [Related]

  • 14. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP, Wooten GF.
    Ann Neurol; 1986 Apr 16; 19(4):378-83. PubMed ID: 3707090
    [Abstract] [Full Text] [Related]

  • 15. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF, Memo M, Govoni S, Trabucchi M.
    Adv Biochem Psychopharmacol; 1980 Apr 16; 24():113-21. PubMed ID: 6105769
    [No Abstract] [Full Text] [Related]

  • 16. Use of ADTN to define specific 3H-spirerone binding to receptors in brain.
    Quik M, Iversen LL, Larder A, Mackay AV.
    Nature; 1978 Aug 03; 274(5670):513-4. PubMed ID: 672981
    [No Abstract] [Full Text] [Related]

  • 17. 3H-Spiroperidol binding and dopamine-stimulated adenylate cyclase: evidence for multiple classes of receptors in primate brain regions.
    Thal LJ, Makman MH, Ahn HS, Mishra RK, Horowitz SG, Dvorkin B, Katzman R.
    Life Sci; 1978 Aug 14; 23(6):629-33. PubMed ID: 99609
    [No Abstract] [Full Text] [Related]

  • 18. Use of [3H]spiperone for labelling dopaminergic and serotonergic receptors in bovine caudate nucleus.
    Withy RM, Mayer RJ, Strange PG.
    J Neurochem; 1981 Nov 14; 37(5):1144-54. PubMed ID: 7299393
    [Abstract] [Full Text] [Related]

  • 19. Quantitative assessment of heterogeneous 3H-spiperone binding to rat neostriatum and frontal cortex.
    Howlett DR, Nahorski SR.
    Life Sci; 1980 Feb 18; 26(7):511-7. PubMed ID: 7366332
    [No Abstract] [Full Text] [Related]

  • 20. Caerulein stimulates [3H]-spiperone binding in vivo after long-term haloperidol administration.
    Vasar E, Maimets M, Nurk A, Allikmets L.
    Psychopharmacol Bull; 1984 Feb 18; 20(4):691-2. PubMed ID: 6494396
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.